237 related articles for article (PubMed ID: 37031809)
21. Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases.
El-Zaafarany GM; Nasr M
Pharm Dev Technol; 2021 Dec; 26(10):1136-1157. PubMed ID: 34751091
[TBL] [Abstract][Full Text] [Related]
22. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
[TBL] [Abstract][Full Text] [Related]
23. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
[No Abstract] [Full Text] [Related]
24. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
25. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Pukale SS; Sharma S; Dalela M; Singh AK; Mohanty S; Mittal A; Chitkara D
Acta Biomater; 2020 Oct; 115():393-409. PubMed ID: 32846238
[TBL] [Abstract][Full Text] [Related]
26. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
Kahraman E; Güngör S; Özsoy Y
Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
[TBL] [Abstract][Full Text] [Related]
27. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
Anita C; Munira M; Mural Q; Shaily L
Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
[TBL] [Abstract][Full Text] [Related]
28. Nanocarrier-Mediated Drug Delivery via Inhalational Route for Lung Cancer Therapy: A Systematic and Updated Review.
Ara N; Hafeez A
AAPS PharmSciTech; 2024 Feb; 25(3):47. PubMed ID: 38424367
[TBL] [Abstract][Full Text] [Related]
29. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
30. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
31. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
32. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
Pradhan M; Singh D; Murthy SN; Singh MR
Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
[TBL] [Abstract][Full Text] [Related]
33. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
[TBL] [Abstract][Full Text] [Related]
34. Nano-Lipidic Carriers as a Tool for Drug Targeting to the Pilosebaceous Units.
Ramkar S; Sah AK; Bhuwane N; Choudhary I; Hemnani N; Suresh PK
Curr Pharm Des; 2020; 26(27):3251-3268. PubMed ID: 32410556
[TBL] [Abstract][Full Text] [Related]
35. Emerging Trends in Topical Delivery of Curcumin Through Lipid Nanocarriers: Effectiveness in Skin Disorders.
Waghule T; Gorantla S; Rapalli VK; Shah P; Dubey SK; Saha RN; Singhvi G
AAPS PharmSciTech; 2020 Oct; 21(7):284. PubMed ID: 33058071
[TBL] [Abstract][Full Text] [Related]
36. Nanotechnological approaches for the effective management of psoriasis.
Garg T; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1374-82. PubMed ID: 25919064
[TBL] [Abstract][Full Text] [Related]
37. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
Puglia C; Bonina F
Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
[TBL] [Abstract][Full Text] [Related]
38. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
39. Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.
Raminelli ACP; Romero V; Semreen MH; Leonardi GR
Curr Med Chem; 2018; 25(31):3703-3718. PubMed ID: 29532749
[TBL] [Abstract][Full Text] [Related]
40. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
Drug Deliv; 2020 Dec; 27(1):662-680. PubMed ID: 32393082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
